Flibanserin 100mg

Flibanserin 100mg – Quick Overview

Flibanserin 100mg is an FDA-approved prescription medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It works by rebalancing neurotransmitters — serotonin, dopamine, and norepinephrine — in the brain that influence sexual desire. It is not a hormonal drug. This medication must be used only under the supervision of a licensed healthcare provider.

Medical Supervision & Regulatory Status

Flibanserin 100mg is a Schedule IV prescription-only medication in the United States, approved by the U.S. Food and Drug Administration (FDA) in August 2015 under the brand name Addyi®. It is available only through a certified prescriber and pharmacy enrolled in the Addyi REMS (Risk Evaluation and Mitigation Strategy) program, due to its risk of severe hypotension and syncope when combined with alcohol or certain medications. Self-medication is not appropriate or safe with this drug.

Clinical Context

Hypoactive sexual desire disorder (HSDD) is a recognized medical condition characterized by persistently low sexual desire that causes notable personal distress. It is not simply a relationship issue or a normal variation in libido — it is a diagnosable condition that can significantly affect quality of life and emotional well-being in premenopausal women.

HSDD is thought to involve an imbalance in key brain chemicals. An excess of serotonin (which inhibits sexual desire) combined with reduced dopamine and norepinephrine (which promote it) may underlie the condition. Without treatment, many women continue to experience distress, relationship difficulties, and reduced self-esteem.

Flibanserin 100mg fills a critical gap in treatment options. Unlike testosterone therapy or psychotherapy alone, it acts centrally on brain chemistry and is the only non-hormonal, FDA-approved pharmacological option specifically indicated for HSDD in premenopausal women.

How Flibanserin 100mg Works

Flibanserin belongs to the drug class of serotonin 1A receptor agonists and serotonin 2A receptor antagonists — a unique mechanism that distinguishes it entirely from hormonal therapies or phosphodiesterase inhibitors used in male sexual dysfunction.

In simple terms, flibanserin acts on specific receptors in the brain to lower serotonin activity while simultaneously increasing the release of dopamine and norepinephrine. Serotonin tends to dampen sexual motivation, while dopamine and norepinephrine are associated with desire, reward, and motivation. By shifting this chemical balance, flibanserin may help restore sexual desire over time.

The benefit for patients is gradual — most clinical improvement is observed after four to eight weeks of consistent nightly use. The drug does not work “on demand” like some medications; it must be taken daily as prescribed to achieve and sustain its therapeutic effect.

What is Flibanserin 100mg?

Drug Class: Serotonin 1A agonist / Serotonin 2A antagonist (CNS agent)

Active Ingredient: Flibanserin

Mechanism: Reduces inhibitory serotonin signaling and increases excitatory dopamine and norepinephrine activity in areas of the brain associated with sexual motivation.

Dosage Form: Oral tablet, 100mg

Dosing Frequency: Once daily at bedtime (to reduce risk of dizziness and low blood pressure)

Regulatory Status: FDA-approved (August 2015); available only via REMS-certified prescribers and pharmacies

Uses / Indications

Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women Flibanserin 100mg is specifically indicated for the treatment of acquired, generalized HSDD in premenopausal adult women. “Acquired” means the condition developed after a period of normal sexual desire. “Generalized” means it occurs regardless of the partner, situation, or type of stimulation.

It is important to note that flibanserin is not indicated for postmenopausal women, men, or individuals whose low desire is caused by a co-existing medical condition, relationship problems, medication side effects, or psychiatric disorders that are separately addressable.

How to Use / Dosage

Flibanserin 100mg is taken once daily at bedtime, not on an as-needed basis. Your doctor will determine whether this medication is appropriate for you based on your full medical history, current medications, and lifestyle factors including alcohol use.

Timing: Always take at bedtime. Taking it during the day significantly increases the risk of low blood pressure, dizziness, and fainting.

Missed Dose: If you miss a dose, skip it entirely and resume your next scheduled bedtime dose. Do not double the dose to compensate for a missed one.

Do Not Stop Suddenly: If you and your doctor decide to discontinue flibanserin, no tapering is typically required — however, always follow your healthcare provider’s instructions and do not stop or restart the medication without consulting them first.

Duration: If there is no meaningful benefit after eight weeks of consistent use, your doctor should re-evaluate whether continued therapy is appropriate.

Side Effects

Most people who take flibanserin 100mg tolerate it reasonably well when used correctly and under medical supervision. Side effects are most commonly related to the central nervous system and are often dose- or timing-related.

Common Side Effects: Dizziness, sleepiness (somnolence), nausea, fatigue, and dry mouth are the most frequently reported effects. These tend to occur more often if the medication is taken at times other than bedtime or if alcohol has been consumed. For many patients, these effects lessen over time as the body adjusts.

Serious Side Effects: The most clinically significant risks include severe low blood pressure (hypotension) and loss of consciousness (syncope), particularly when flibanserin is combined with alcohol, certain antifungal medications, or other CNS depressants. These effects may occur even with a single alcoholic drink.

Seek Emergency Medical Attention Immediately If You Experience:

• Sudden fainting or loss of consciousness
• Severe dizziness or inability to stand
• Unusually slow or irregular heartbeat
• Extreme confusion or disorientation
• Difficulty breathing
• Chest pain or pressure
• Severe nausea with inability to remain upright

Warnings & Precautions

Alcohol Interaction — Boxed Warning: The FDA has issued a Black Box Warning regarding the combination of flibanserin and alcohol. Even moderate alcohol consumption significantly increases the risk of severe hypotension and syncope. Patients must completely abstain from alcohol during flibanserin therapy. This is a non-negotiable safety requirement.

Drug Interactions: Flibanserin is metabolized by the CYP3A4 enzyme system. Strong or moderate CYP3A4 inhibitors — including fluconazole, ketoconazole, itraconazole, clarithromycin, and certain HIV protease inhibitors — are contraindicated or require extreme caution, as they can dramatically raise flibanserin blood levels and increase adverse effects. CNS depressants such as benzodiazepines, sleep aids, and opioids may compound sedation and hypotension risk.

Pregnancy and Breastfeeding: Flibanserin has not been adequately studied in pregnant women. It should not be used during pregnancy. Whether it passes into breast milk is not established, so breastfeeding while on this medication is not recommended. Discuss reproductive plans openly with your physician.

Liver Impairment: Flibanserin is contraindicated in patients with any degree of hepatic (liver) impairment, as reduced liver function leads to significantly elevated drug concentrations and substantially increased risk of side effects.

Special Populations: Safety and efficacy in women over 65, adolescents under 18, or patients with severe psychiatric comorbidities have not been established. Flibanserin has not been studied in postmenopausal women and is not approved for that population.

Monitoring: Patients should be counseled at initiation and monitored periodically for blood pressure, CNS effects, and treatment response. A formal reassessment of benefit versus risk is recommended after eight weeks.

Who Should Not Use This Medication

• Women who are postmenopausal or male patients (not an approved indication)
• Anyone with liver disease or hepatic impairment of any severity
• Patients currently taking strong or moderate CYP3A4 inhibitors
• Individuals who consume alcohol regularly and are unable to abstain completely
• Pregnant or breastfeeding women
• Patients with a history of hypotension or syncope
• Those taking other CNS depressants without physician approval
• Individuals under 18 years of age

Storage Instructions

Temperature: Store flibanserin 100mg tablets at room temperature between 68°F and 77°F (20°C–25°C). Brief excursions to 59°F–86°F (15°C–30°C) are permitted.

Moisture and Light: Store in a dry place, away from direct light and humidity. Do not store in the bathroom medicine cabinet, which is prone to moisture fluctuations.

Child Safety: Keep this medication in its original container with the cap tightly closed, stored well out of reach and sight of children. Accidental ingestion by a child is a medical emergency — contact Poison Control immediately at 1-800-222-1222 (US).

Frequently Asked Questions

Does flibanserin 100mg require a prescription?

Yes, flibanserin is a prescription-only medication available exclusively through REMS-certified prescribers. It cannot be purchased over the counter. Your doctor will evaluate whether it is appropriate for you based on your complete medical and medication history before prescribing it.

How long does it take for flibanserin 100mg to work?

Flibanserin is not an on-demand medication — it must be taken daily. Most patients begin noticing meaningful improvement in sexual desire and reduction in distress after four to eight weeks of consistent nightly use. If no benefit is observed by eight weeks, your doctor should reassess your treatment plan.

Can I drink alcohol while taking flibanserin 100mg?

No. Alcohol is strictly contraindicated with flibanserin due to a serious risk of severe low blood pressure and fainting, even with a single drink. The FDA has issued a Black Box Warning on this interaction. Complete alcohol abstinence is mandatory throughout the entire duration of flibanserin therapy.

Can I stop taking flibanserin 100mg suddenly?

Flibanserin does not typically require tapering, but you should never stop or restart any prescription medication without first consulting your doctor. Stopping abruptly may simply result in the return of HSDD symptoms, but your physician should guide any changes to your treatment plan.

Does flibanserin interact with any common medications?

Yes, significantly. Strong CYP3A4 inhibitors — including fluconazole, ketoconazole, and certain antibiotics and antiviral drugs, are contraindicated with flibanserin. CNS depressants like sleep aids, benzodiazepines, and opioids also carry interaction risks. Always disclose your full medication list, including supplements, to your prescriber.

What happens if I miss a dose of flibanserin?

Skip the missed dose entirely and take your next dose at your usual bedtime. Never take two doses in one day to make up for a missed one. Taking flibanserin outside of bedtime hours substantially increases your risk of dizziness, low blood pressure, and fainting during waking hours.

Is flibanserin the same as “female Viagra”?

No. Flibanserin is frequently mischaracterized this way, but it works entirely differently. Sildenafil (Viagra) increases genital blood flow on demand. Flibanserin acts on brain neurotransmitters daily to address the underlying neurochemical cause of low desire. It does not work on-demand and has no effect on genital blood flow.

References

Regulatory & Clinical References

• FDA Drug Label – Flibanserin (Addyi®) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526lbl.pdf
• DailyMed – Flibanserin Official Prescribing Information (NIH) https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=flibanserin
• MedlinePlus – Flibanserin https://medlineplus.gov/druginfo/meds/a615048.html
• FDA Drug Safety Communication – Addyi REMS Program https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/addyi-flibanserin-information
• NIH National Library of Medicine – HSDD Overview https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003227/
• American College of Obstetricians and Gynecologists (ACOG) – Female Sexual Dysfunction https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2019/03/female-sexual-dysfunction
• ClinicalTrials.gov – Flibanserin Clinical Trials https://clinicaltrials.gov/search?term=flibanserin
• Sprout Pharmaceuticals / Addyi Official Website https://www.addyi.com